Bivalent is better. Simple is better,” one FDA committee member said about vaccines that tackle the original strains of COVID ...

The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine ...

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

The U.S. Food and Drug Administration’s key science advisory panel, the Vaccines and Related Biological Products Advisory ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

Protecting against Covid infection with the current mRNA technology is unrealistic, a vaccine expert said in a paper ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant's bivalent Covid booster. Vaccine advisors who signed off on ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...